The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis - PDF (Russian)
Copyright (c) 2019 Consilium Medicum
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.